171 related articles for article (PubMed ID: 38381172)
1. Clinical characteristics and outcomes of allogeneic hematopoietic stem cell transplantation recipients with coronavirus disease 2019 caused by the Omicron variant: a prospective, observational cohort study.
Fan S; Mo X; Zhang X; Xu L; Wang Y; Yan C; Chen H; Zhang Y; Cheng Y; Sun Y; Chen Y; Chen Y; Han W; Wang J; Wang F; Xu Z; Huang X
Ann Hematol; 2024 Apr; 103(4):1333-1344. PubMed ID: 38381172
[TBL] [Abstract][Full Text] [Related]
2. Favorable outcomes of COVID-19 in vaccinated hematopoietic stem cell transplant recipients: A single-center experience.
Tan JY; Wee LE; Tan YH; Conceicao EP; Lim FWI; Chen Y; Than H; Quek JKS; Nagarajan C; Goh YT; Hwang WYK; Phua GC; Chung SJ; Tan TT; Linn YC; Ho AYL; Tan BH
Transpl Infect Dis; 2023 Jun; 25(3):e14024. PubMed ID: 36715661
[TBL] [Abstract][Full Text] [Related]
3. Outcomes and Management of the SARS-CoV2 Omicron Variant in Recipients of Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy.
Infante MS; Nemirovsky D; Devlin S; DeWolf S; Tamari R; Dahi PB; Lee YJ; Chung DJ; Politikos I; Barker J; Giralt SA; Babady NE; Ramanathan L; Papanicolaou GA; Seo S; Kamboj M; Perales MA; Shah GL
Transplant Cell Ther; 2024 Jan; 30(1):116.e1-116.e12. PubMed ID: 37806446
[TBL] [Abstract][Full Text] [Related]
4. Impact of SARS-CoV-2 in Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Recipients.
Mushtaq MU; Shahzad M; Chaudhary SG; Luder M; Ahmed N; Abdelhakim H; Bansal R; Balusu R; DeJarnette S; Divine C; Kribs R; Shune L; Singh AK; Ganguly S; Abhyankar SH; McGuirk JP
Transplant Cell Ther; 2021 Sep; 27(9):796.e1-796.e7. PubMed ID: 34256172
[TBL] [Abstract][Full Text] [Related]
5. Ursodeoxycholic acid does not reduce SARS-CoV-2 infection in newly allogeneic hematopoietic stem cell transplantation recipients: a prospective NICHE cohort.
Gao H; Wang J; Zheng X; Pei X; Zheng Y; Zhai W; Zhang R; Chen X; Ma Q; Wei J; Yang D; Pang A; He Y; Feng S; Cao Y; Jiang E
Front Cell Infect Microbiol; 2024; 14():1324019. PubMed ID: 38505288
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for a severe disease course in children with SARS-COV-2 infection following hematopoietic cell transplantation in the pre-Omicron period: a prospective multinational Infectious Disease Working Party from the European Society for Blood and Marrow Transplantation group (EBMT) and the Spanish Group of Hematopoietic Stem Cell Transplantation (GETH) study.
Averbuch D; de la Camara R; Tridello G; Knelange NS; Bykova TA; Ifversen M; Dobsinska V; Ayas M; Hamidieh AA; Pichler H; Perez-Martinez A; Cesaro S; Sundin M; Badell I; Bader P; Johansson JE; Mirci-Danicar O; Sedlacek P; Paillard C; Gibson B; Lawson S; Kroeger N; Corbacioglu S; Mikulska M; Piñana JL; Styczynski J; Ljungman P
Bone Marrow Transplant; 2023 May; 58(5):558-566. PubMed ID: 36849806
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study.
Sharma A; Bhatt NS; St Martin A; Abid MB; Bloomquist J; Chemaly RF; Dandoy C; Gauthier J; Gowda L; Perales MA; Seropian S; Shaw BE; Tuschl EE; Zeidan AM; Riches ML; Shah GL
Lancet Haematol; 2021 Mar; 8(3):e185-e193. PubMed ID: 33482113
[TBL] [Abstract][Full Text] [Related]
8. Three doses of a recombinant conjugated SARS-CoV-2 vaccine early after allogeneic hematopoietic stem cell transplantation: predicting indicators of a high serologic response-a prospective, single-arm study.
Barkhordar M; Chahardouli B; Biglari A; Ahmadvand M; Bahri T; Alaeddini F; Sharifi Aliabadi L; Noorani SS; Bagheri Amiri F; Biglari M; Shemshadi MR; Ghavamzadeh A; Vaezi M
Front Immunol; 2023; 14():1169666. PubMed ID: 37153556
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and Safety of Booster SARS-CoV-2 mRNA Vaccine Dose in Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
Mittal A; Solera JT; Ferreira VH; Kothari S; Kimura M; Pasic I; Mattsson JI; Humar A; Kulasingam V; Ierullo M; Kumar D; Hosseini-Moghaddam SM
Transplant Cell Ther; 2023 Nov; 29(11):706.e1-706.e7. PubMed ID: 37582470
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 disease in children and adolescents following allogeneic hematopoietic stem cell transplantation: A report from the Turkish pediatric bone marrow transplantation study group.
Bozkurt C; Hazar V; Malbora B; Küpesiz A; Aygüneş U; Fışgın T; Karakükçü M; Kuşkonmaz B; Kılıç SÇ; Bayırlı D; Arman Bilir Ö; Yalçın K; Gözmen S; Uygun V; Elli M; Sarbay H; Küpesiz FT; Şaşmaz Hİ; Aksoy BA; Yılmaz E; Okur FV; Tekkeşin F; Yenigürbüz FD; Özek G; Atay AA; Bozkaya İO; Çelen S; Öztürkmen S; Güneş AM; Gürsel O; Güler E; Özcan A; Çetinkaya DU; Aydoğdu S; Özbek NY; Karasu G; Sezgin G; Doğru Ö; Albayrak D; Öztürk G; Aksoylar S; Daloğlu H; Odaman Al I; Evim MS; Akbayram S; Öncül Y; Zengin E; Albayrak C; Timur Ç; Kar YD; Çakmaklı HF; Tüfekçi Ö; Töret E; Antmen B
Pediatr Transplant; 2024 May; 28(3):e14758. PubMed ID: 38659218
[TBL] [Abstract][Full Text] [Related]
11. Impact of COVID-19 in hematopoietic stem cell transplant recipients: A systematic review and meta-analysis.
Shahzad M; Chaudhary SG; Zafar MU; Hassan MA; Hussain A; Ali F; Anwar I; Ahmed M; Ahmed N; Khurana S; Rauf MA; Anwar F; Hematti P; Callander NS; Abhyankar SH; McGuirk JP; Mushtaq MU
Transpl Infect Dis; 2022 Apr; 24(2):e13792. PubMed ID: 35030267
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 was associated with the complications after allogeneic hematopoietic stem cell transplantation.
Wen Q; Guo Z; Zhang XH; Xu LP; Wang Y; Yan CH; Chen H; Chen YH; Han W; Wang FR; Sun YQ; Huang XJ; Mo XD
Sci Rep; 2024 May; 14(1):11778. PubMed ID: 38782966
[TBL] [Abstract][Full Text] [Related]
13. Pre-exposure prophylaxis with tixagevimab/cilgavimab (AZD7442) prevents severe SARS-CoV-2 infection in recipients of allogeneic hematopoietic stem cell transplantation during the Omicron wave: a multicentric retrospective study of SFGM-TC.
Jondreville L; D'Aveni M; Labussière-Wallet H; Le Bourgeois A; Villate A; Berceanu A; Bezsera SM; Thiebaut A; Boissard-Simonet M; Legrand M; Cornillon J; Rubio MT; Chevallier P; Nguyen S
J Hematol Oncol; 2022 Nov; 15(1):169. PubMed ID: 36443846
[TBL] [Abstract][Full Text] [Related]
14. Case Report: Favorable outcome of allogeneic hematopoietic stem cell transplantation in SARSCoV2 positive recipient, risk-benefit balance between infection and leukemia.
Oltolini C; Acerbis A; Orofino G; Racca S; Noviello M; Dispinseri S; Clementi N; Piemontese S; Xue E; Giglio F; Lupo Stanghellini MT; Diral E; Bruno A; Tassi E; Beretta V; Marzinotto I; Scarlatti G; Lampasona V; Ardemagni A; Sampaolo M; Bonini C; Corti C; Peccatori J; Castagna A; Ciceri F; Greco R
Front Immunol; 2023; 14():1184956. PubMed ID: 37287986
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of Coronavirus Disease in Allogeneic Hematopoietic Stem Cell Transplantation During the Omicron Wave: A Single-Center Study.
Zhu P; Yang L; Liu L; Lai X; Shi J; Zhao Y; Yu J; Fu H; Ye Y; Wu Y; Huang H; Luo Y
Open Forum Infect Dis; 2024 Mar; 11(3):ofae038. PubMed ID: 38481430
[TBL] [Abstract][Full Text] [Related]
16. Impact of prior COVID-19 infection on allogeneic hematopoietic stem cell transplantation outcomes.
Siniaev A; Popova M; Rogacheva Y; Ianbukhtina V; Kulagin E; Vladovskaya M; Bondarenko S; Moiseev I; Kulagin AD
Clin Transplant; 2024 May; 38(5):e15331. PubMed ID: 38757924
[TBL] [Abstract][Full Text] [Related]
17. Clinical Characteristics and Outcomes of Immunocompromised Patients With Coronavirus Disease 2019 Caused by the Omicron Variant: A Prospective, Observational Study.
Malahe SRK; Hoek RAS; Dalm VASH; Broers AEC; den Hoed CM; Manintveld OC; Baan CC; van Deuzen CM; Papageorgiou G; Bax HI; Van Kampen JJ; Hellemons ME; Kho MML; de Vries RD; Molenkamp R; Reinders MEJ; Rijnders BJA
Clin Infect Dis; 2023 Feb; 76(3):e172-e178. PubMed ID: 35869843
[TBL] [Abstract][Full Text] [Related]
18. Incidence, risk factors, and outcome of pulmonary invasive fungal disease after respiratory virus infection in allogeneic hematopoietic stem cell transplantation recipients.
Piñana JL; Gómez MD; Montoro J; Lorenzo I; Pérez A; Giménez E; González-Barberá EM; Carretero C; Guerreiro M; Salavert M; Sanz G; Hernández-Boluda JC; Borrás R; Sanz J; Solano C; Navarro D
Transpl Infect Dis; 2019 Oct; 21(5):e13158. PubMed ID: 31402532
[TBL] [Abstract][Full Text] [Related]
19. Specific immune response to mRNA vaccines against COVID-19 in patients receiving allogeneic stem cell transplantation for myeloid malignancy was altered by immunosuppressive therapy.
Macková J; Hainz P; Kryštofová J; Roubalová K; Šťastná-Marková M; Vaníková Š; Musil J; Vydra J; Němečková Š
Leuk Res; 2023 Jul; 130():107314. PubMed ID: 37216792
[TBL] [Abstract][Full Text] [Related]
20. Clinical Characteristics and Outcomes of COVID-19 in Pediatric and Early Adolescent and Young Adult Hematopoietic Stem Cell Transplant Recipients: A Cohort Study.
Bhatt NS; Sharma A; St Martin A; Abid MB; Brown VI; Diaz Perez MA; Frangoul H; Gadalla SM; Herr MM; Krem MM; Lazarus HM; Martens MJ; Mehta PA; Nishihori T; Prestidge T; Pulsipher MA; Rangarajan HG; Williams KM; Winestone LE; Yin DE; Riches ML; Dandoy CE; Auletta JJ
Transplant Cell Ther; 2022 Oct; 28(10):696.e1-696.e7. PubMed ID: 35798233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
